$CCXI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ChemoCentryx, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ChemoCentryx, Inc.. Get notifications about new insider transactions in ChemoCentryx, Inc. for free.
Page: < prev 1 ... 6 7 8 9 10 11 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 5,000 | 21,500 | 112,500 | |
Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 99 | 426 | 117,500 | |
Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 7,401 | 31,824 | 117,599 | |
Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 99 | 426 | 125,000 | |
Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 7,401 | 31,824 | 125,099 | |
Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 99 | 426 | 132,500 | |
Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.40 | 2,401 | 29,775 | 45,000 | 47.4 K to 45 K (-5.07 %) |
Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 2,401 | 10,324 | 47,401 | 45 K to 47.4 K (+5.34 %) |
Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.35 | 5,000 | 61,772 | 45,000 | 50 K to 45 K (-10.00 %) |
Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 5,000 | 21,500 | 50,000 | 45 K to 50 K (+11.11 %) |
Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.22 | 99 | 1,210 | 45,000 | 45.1 K to 45 K (-0.22 %) |
Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 99 | 426 | 45,099 | 45 K to 45.1 K (+0.22 %) |
Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.28 | 7,401 | 90,875 | 45,000 | 52.4 K to 45 K (-14.12 %) |
Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 7,401 | 31,824 | 52,401 | 45 K to 52.4 K (+16.45 %) |
Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.04 | 99 | 1,192 | 45,000 | 45.1 K to 45 K (-0.22 %) |
Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 99 | 426 | 45,099 | 45 K to 45.1 K (+0.22 %) |
Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 12.05 | 7,401 | 89,206 | 45,000 | 52.4 K to 45 K (-14.12 %) |
Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 7,401 | 31,824 | 52,401 | 45 K to 52.4 K (+16.45 %) |
Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.89 | 99 | 1,177 | 45,000 | 45.1 K to 45 K (-0.22 %) |
Feb 26 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 99 | 426 | 45,099 | 45 K to 45.1 K (+0.22 %) |
Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 1,100 | 4,730 | 132,599 | |
Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 5,601 | 24,084 | 133,699 | |
Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 700 | 3,010 | 139,300 | |
Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 6,800 | 29,240 | 140,000 | |
Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.89 | 1,100 | 13,079 | 45,000 | 46.1 K to 45 K (-2.39 %) |
Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 1,100 | 4,730 | 46,100 | 45 K to 46.1 K (+2.44 %) |
Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.90 | 5,601 | 66,633 | 45,000 | 50.6 K to 45 K (-11.07 %) |
Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 5,601 | 24,084 | 50,601 | 45 K to 50.6 K (+12.45 %) |
Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.95 | 8,000 | 95,600 | 45,000 | 53 K to 45 K (-15.09 %) |
Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.85 | 700 | 8,295 | 53,000 | 53.7 K to 53 K (-1.30 %) |
Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 700 | 3,010 | 53,700 | 53 K to 53.7 K (+1.32 %) |
Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.86 | 6,800 | 80,640 | 53,000 | 59.8 K to 53 K (-11.37 %) |
Feb 21 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 6,800 | 29,240 | 59,800 | 53 K to 59.8 K (+12.83 %) |
Feb 19 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 700 | 3,010 | 146,800 | |
Feb 19 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 1,245 | 5,354 | 147,500 | |
Feb 19 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.78 | 700 | 8,244 | 53,000 | 53.7 K to 53 K (-1.30 %) |
Feb 19 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 700 | 3,010 | 53,700 | 53 K to 53.7 K (+1.32 %) |
Feb 19 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.71 | 1,245 | 14,581 | 53,000 | 54.2 K to 53 K (-2.30 %) |
Feb 19 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 1,245 | 5,354 | 54,245 | 53 K to 54.2 K (+2.35 %) |
Feb 14 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 3,676 | 2,206 | 33,733 | |
Feb 14 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 4.30 | 1,783 | 7,667 | 37,519 | |
Feb 14 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 11.45 | 3,676 | 42,087 | 75,000 | 78.7 K to 75 K (-4.67 %) |
Feb 14 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 3,676 | 2,206 | 78,676 | 75 K to 78.7 K (+4.90 %) |
Feb 14 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 11.45 | 1,783 | 20,409 | 75,000 | 76.8 K to 75 K (-2.32 %) |
Feb 14 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 4.30 | 1,783 | 7,667 | 76,783 | 75 K to 76.8 K (+2.38 %) |
Feb 08 2013 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 11.27 | 1,143 | 12,884 | 70,000 | 71.1 K to 70 K (-1.61 %) |
Feb 06 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 3,100 | 13,330 | 150,300 | |
Feb 06 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 775 | 3,333 | 153,400 | |
Feb 06 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.69 | 3,100 | 36,254 | 53,000 | 56.1 K to 53 K (-5.53 %) |
Feb 06 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 3,100 | 13,330 | 56,100 | 53 K to 56.1 K (+5.85 %) |
Feb 06 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.67 | 775 | 9,041 | 53,000 | 53.8 K to 53 K (-1.44 %) |
Feb 06 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 775 | 3,333 | 53,775 | 53 K to 53.8 K (+1.46 %) |
Feb 08 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 1,555 | 6,687 | 148,745 | |
Feb 08 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.65 | 1,555 | 18,116 | 53,000 | 54.6 K to 53 K (-2.85 %) |
Feb 08 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 1,555 | 6,687 | 54,555 | 53 K to 54.6 K (+2.93 %) |
Feb 06 2013 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 11.29 | 757 | 8,548 | 71,143 | 71.9 K to 71.1 K (-1.05 %) |
Feb 06 2013 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 11.34 | 800 | 9,069 | 71,900 | 72.7 K to 71.9 K (-1.10 %) |
Feb 06 2013 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 11.66 | 2,300 | 26,809 | 72,700 | 75 K to 72.7 K (-3.07 %) |
Feb 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 6,725 | 28,918 | 154,175 | |
Feb 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 3,280 | 14,104 | 160,900 | |
Feb 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.65 | 1,600 | 18,640 | 53,000 | 54.6 K to 53 K (-2.93 %) |
Feb 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 1,600 | 6,880 | 54,600 | 53 K to 54.6 K (+3.02 %) |
Feb 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.60 | 5,125 | 59,466 | 53,000 | 58.1 K to 53 K (-8.82 %) |
Feb 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 5,125 | 22,038 | 58,125 | 53 K to 58.1 K (+9.67 %) |
Feb 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.57 | 1,600 | 18,516 | 53,000 | 54.6 K to 53 K (-2.93 %) |
Feb 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 1,600 | 6,880 | 54,600 | 53 K to 54.6 K (+3.02 %) |
Feb 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.45 | 1,680 | 19,236 | 53,000 | 54.7 K to 53 K (-3.07 %) |
Feb 01 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 1,680 | 7,224 | 54,680 | 53 K to 54.7 K (+3.17 %) |
Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 4,892 | 21,036 | 164,180 | |
Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 2,710 | 11,653 | 169,072 | |
Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 96 | 413 | 171,782 | |
Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.45 | 4,892 | 56,013 | 53,000 | 57.9 K to 53 K (-8.45 %) |
Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 4,892 | 21,036 | 57,892 | 53 K to 57.9 K (+9.23 %) |
Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.45 | 928 | 10,626 | 53,000 | 53.9 K to 53 K (-1.72 %) |
Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 928 | 3,990 | 53,928 | 53 K to 53.9 K (+1.75 %) |
Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.35 | 1,782 | 20,226 | 53,000 | 54.8 K to 53 K (-3.25 %) |
Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 1,782 | 7,663 | 54,782 | 53 K to 54.8 K (+3.36 %) |
Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.35 | 96 | 1,090 | 53,000 | 53.1 K to 53 K (-0.18 %) |
Jan 29 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 96 | 413 | 53,096 | 53 K to 53.1 K (+0.18 %) |
Jan 24 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 1,200 | 5,160 | 171,878 | |
Jan 24 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 100 | 430 | 173,078 | |
Jan 24 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.35 | 1,200 | 13,622 | 53,000 | 54.2 K to 53 K (-2.21 %) |
Jan 24 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 1,200 | 5,160 | 54,200 | 53 K to 54.2 K (+2.26 %) |
Jan 24 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.35 | 100 | 1,135 | 53,000 | 53.1 K to 53 K (-0.19 %) |
Jan 24 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 100 | 430 | 53,100 | 53 K to 53.1 K (+0.19 %) |
Jan 22 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 2,759 | 1,655 | 37,409 | |
Jan 22 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 11.16 | 2,759 | 30,799 | 75,000 | 77.8 K to 75 K (-3.55 %) |
Jan 22 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 2,759 | 1,655 | 77,759 | 75 K to 77.8 K (+3.68 %) |
Jan 17 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 917 | 550 | 40,168 | |
Jan 17 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 4.30 | 383 | 1,647 | 39,302 | |
Jan 17 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 4.30 | 600 | 2,580 | 39,685 | |
Jan 17 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 4.30 | 800 | 3,440 | 40,285 | |
Jan 17 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 11.16 | 917 | 10,231 | 75,000 | 75.9 K to 75 K (-1.21 %) |
Jan 17 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 917 | 550 | 75,917 | 75 K to 75.9 K (+1.22 %) |
Jan 17 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 11.15 | 383 | 4,270 | 75,000 | 75.4 K to 75 K (-0.51 %) |
Jan 17 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 4.30 | 383 | 1,647 | 75,383 | 75 K to 75.4 K (+0.51 %) |
Jan 17 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 11.18 | 600 | 6,705 | 75,000 | 75.6 K to 75 K (-0.79 %) |
Jan 17 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 4.30 | 600 | 2,580 | 75,600 | 75 K to 75.6 K (+0.80 %) |
Jan 17 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 11.15 | 800 | 8,920 | 75,000 | 75.8 K to 75 K (-1.06 %) |
Jan 17 2013 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 4.30 | 800 | 3,440 | 75,800 | 75 K to 75.8 K (+1.07 %) |
Jan 15 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 3,305 | 14,212 | 173,178 | |
Jan 15 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.35 | 3,305 | 37,512 | 53,000 | 56.3 K to 53 K (-5.87 %) |
Jan 15 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 3,305 | 14,212 | 56,305 | 53 K to 56.3 K (+6.24 %) |
Jan 09 2013 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 11.00 | 2,099 | 23,098 | 75,000 | 77.1 K to 75 K (-2.72 %) |
Jan 09 2013 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 11.16 | 1,800 | 20,094 | 77,099 | 78.9 K to 77.1 K (-2.28 %) |
Jan 04 2013 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 11.08 | 700 | 7,759 | 78,899 | 79.6 K to 78.9 K (-0.88 %) |
Jan 04 2013 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 11.10 | 401 | 4,453 | 79,599 | 80 K to 79.6 K (-0.50 %) |
Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 96 | 413 | 176,483 | |
Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 100 | 430 | 176,579 | |
Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 5,821 | 25,030 | 176,679 | |
Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.35 | 96 | 1,090 | 53,000 | 53.1 K to 53 K (-0.18 %) |
Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 96 | 413 | 53,096 | 53 K to 53.1 K (+0.18 %) |
Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.35 | 100 | 1,135 | 53,000 | 53.1 K to 53 K (-0.19 %) |
Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 100 | 430 | 53,100 | 53 K to 53.1 K (+0.19 %) |
Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.35 | 821 | 9,318 | 53,000 | 53.8 K to 53 K (-1.53 %) |
Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 821 | 3,530 | 53,821 | 53 K to 53.8 K (+1.55 %) |
Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.25 | 5,000 | 56,250 | 53,000 | 58 K to 53 K (-8.62 %) |
Jan 04 2013 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 5,000 | 21,500 | 58,000 | 53 K to 58 K (+9.43 %) |
Dec 04 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 4,693 | 9,386 | 177,500 | |
Dec 04 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 404 | 808 | 182,193 | |
Dec 04 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 830 | 1,660 | 182,597 | |
Dec 04 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 11.98 | 4,693 | 56,217 | 0 | 4.7 K to 0 (-100.00 %) |
Dec 04 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 4,693 | 9,386 | 4,693 | 0 to 4.7 K |
Dec 04 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 11.93 | 404 | 4,818 | 0 | 404 to 0 (-100.00 %) |
Dec 04 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 404 | 808 | 404 | 0 to 404 |
Dec 04 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 11.94 | 830 | 9,910 | 0 | 830 to 0 (-100.00 %) |
Dec 04 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 830 | 1,660 | 830 | 0 to 830 |
Dec 20 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 4.30 | 1,783 | 7,667 | 41,085 | |
Dec 20 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Option Exercise | M | 0.60 | 3,060 | 1,836 | 44,120 | |
Dec 20 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 10.94 | 1,783 | 19,507 | 75,000 | 76.8 K to 75 K (-2.32 %) |
Dec 20 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 4.30 | 1,783 | 7,667 | 76,783 | 75 K to 76.8 K (+2.38 %) |
Dec 20 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Sell | S | 10.94 | 3,060 | 33,477 | 75,000 | 78.1 K to 75 K (-3.92 %) |
Dec 20 2012 | CCXI | ChemoCentryx, Inc. | Cappel Markus J. | Chief Bus. Officer ... | Buy | M | 0.60 | 3,060 | 1,836 | 78,060 | 75 K to 78.1 K (+4.08 %) |
Dec 19 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 7,500 | 32,250 | 182,500 | |
Dec 19 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Option Exercise | M | 4.30 | 7,500 | 32,250 | 190,000 | |
Dec 19 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.05 | 2,500 | 27,625 | 53,000 | 55.5 K to 53 K (-4.50 %) |
Dec 19 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 2,500 | 10,750 | 55,500 | 53 K to 55.5 K (+4.72 %) |
Dec 19 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.15 | 5,000 | 55,750 | 53,000 | 58 K to 53 K (-8.62 %) |
Dec 19 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 5,000 | 21,500 | 58,000 | 53 K to 58 K (+9.43 %) |
Dec 19 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 11.05 | 2,500 | 27,625 | 53,000 | 55.5 K to 53 K (-4.50 %) |
Dec 19 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 2,500 | 10,750 | 55,500 | 53 K to 55.5 K (+4.72 %) |
Dec 19 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Sell | S | 10.95 | 5,000 | 54,750 | 53,000 | 58 K to 53 K (-8.62 %) |
Dec 19 2012 | CCXI | ChemoCentryx, Inc. | Jaen Juan C. | SVP, Drug Discovery ... | Buy | M | 4.30 | 5,000 | 21,500 | 58,000 | 53 K to 58 K (+9.43 %) |
Dec 04 2012 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 11.97 | 4,800 | 57,443 | 80,000 | 84.8 K to 80 K (-5.66 %) |
Dec 04 2012 | CCXI | ChemoCentryx, Inc. | LUCAS ROGER C | Director | Sell | S | 11.72 | 200 | 2,344 | 84,800 | 85 K to 84.8 K (-0.24 %) |
Nov 30 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 3,839 | 7,678 | 183,427 | |
Nov 30 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Option Exercise | M | 2.00 | 234 | 468 | 187,266 | |
Nov 30 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 11.89 | 3,839 | 45,663 | 0 | 3.8 K to 0 (-100.00 %) |
Nov 30 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Buy | M | 2.00 | 3,839 | 7,678 | 3,839 | 0 to 3.8 K |
Nov 30 2012 | CCXI | ChemoCentryx, Inc. | KANAYA SUSAN M | SVP, Finance, CFO a ... | Sell | S | 11.90 | 234 | 2,784 | 0 | 234 to 0 (-100.00 %) |